ABION, Inc. engages in the development of biopharmaceuticals for treating incurable diseases. Its products include protein, nucleic acid, and antibody therapeutics. The company was founded on April 16, 2007 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company